Cargando…

Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease

Alcoholic liver disease (ALD) is a globally prevalent chronic liver disease caused by chronic or binge consumption of alcohol. The therapeutic efficiency of current therapies for ALD is limited, and there is no FDA-approved therapy for ALD at present. Various strategies targeting pathogenic events i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Jinsol, Lee, Chanbin, Hur, Jin, Jung, Youngmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818513/ https://www.ncbi.nlm.nih.gov/pubmed/36611816 http://dx.doi.org/10.3390/cells12010022

Ejemplares similares

Mesenchymal Stem Cells Influence Activation of Hepatic Stellate Cells, and Constitute a Promising Therapy for Liver Fibrosis
por: Lee, Chanbin, et al.
Publicado: (2021)

Pathophysiological Aspects of Alcohol Metabolism in the Liver
por: Hyun, Jeongeun, et al.
Publicado: (2021)

Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver
por: Lee, Chanbin, et al.
Publicado: (2023)

Pathological Contribution of Extracellular Vesicles and Their MicroRNAs to Progression of Chronic Liver Disease
por: Lee, Chanbin, et al.
Publicado: (2022)

Deficiency of Formyl Peptide Receptor 2 Retards Hair Regeneration by Modulating the Activation of Hair Follicle Stem Cells and Dermal Papilla Cells in Mice
por: Han, Jinsol, et al.
Publicado: (2021)

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2019)

Targeted Deletion of Thymosin Beta 4 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in a Transgenic Mouse Model
por: Kim, Jieun, et al.
Publicado: (2023)

sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p
por: Kim, Jieun, et al.
Publicado: (2021)

MicroRNA-378 is involved in hedgehog-driven epithelial-to-mesenchymal transition in hepatocytes of regenerating liver
por: Kim, Jieun, et al.
Publicado: (2018)

Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2022)

Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
por: Vajro, Pietro, et al.
Publicado: (2012)

Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy
por: Cofano, Fabio, et al.
Publicado: (2019)

Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
por: Hmadcha, Abdelkrim, et al.
Publicado: (2020)

Hepatoprotective Effect of Kombucha Tea in Rodent Model of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2019)

MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells
por: Hyun, Jeongeun, et al.
Publicado: (2015)

Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Tumor necrosis factor-inducible gene 6 protein ameliorates chronic liver damage by promoting autophagy formation in mice
por: Wang, Sihyung, et al.
Publicado: (2017)

Mesenchymal stem cells-based therapy in liver diseases
por: Han, Heng-Tong, et al.
Publicado: (2022)

Tumor necrosis factor-inducible gene 6 interacts with CD44, which is involved in fate-change of hepatic stellate cells
por: Wang, Sihyung, et al.
Publicado: (2020)

Therapeutic potential of mesenchymal stem cell based therapy for osteoarthritis
por: Burke, John, et al.
Publicado: (2016)

Editorial Expression of Concern: Tumor necrosis factor-inducible gene 6 protein ameliorates chronic liver damage by promoting autophagy formation in mice
por: Wang, Sihyung, et al.
Publicado: (2021)

The current understanding and potential therapeutic options to combat COVID-19
por: Pooladanda, Venkatesh, et al.
Publicado: (2020)

Potential therapeutic options for COVID-19: an update on current evidence
por: Niknam, Zahra, et al.
Publicado: (2022)

Radiation-induced liver disease: current understanding and future perspectives
por: Kim, Jieun, et al.
Publicado: (2017)

Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
por: Al-Khawaga, Sara, et al.
Publicado: (2020)

Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases
por: Műzes, Györgyi, et al.
Publicado: (2022)

Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review
por: Tidwell, Jasmine, et al.
Publicado: (2023)

An overview of mesenchymal stem cells and their potential therapeutic benefits in cancer therapy
por: Lim, Shern Kwok, et al.
Publicado: (2021)

A Review on Currently Available Potential Therapeutic Options for COVID-19
por: Ohadian Moghadam, Solmaz
Publicado: (2020)

The therapeutic potential of mesenchymal stem cells in treating osteoporosis
por: Chen, Tianning, et al.
Publicado: (2021)

The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future
por: Zhang, Sainan, et al.
Publicado: (2020)

Current Therapeutic Options for Alzheimer’s Disease
por: Lleó, Alberto
Publicado: (2007)

Primary myelofibrosis: current therapeutic options
por: de Melo Campos, Paula
Publicado: (2016)

Current therapeutic options for gastric adenocarcinoma
por: Akshatha, C.R., et al.
Publicado: (2021)

Mesenchymal Stem Cell Transplantation for Liver Cell Failure: A New Direction and Option
por: Cao, Yantian, et al.
Publicado: (2018)

Current understanding of mesenchymal stem cells in liver diseases
por: Wu, Mu-Chen, et al.
Publicado: (2021)

Mesenchymal Stromal Cells: From Therapeutic Option to Therapeutic Target
por: Stefani, Francesca Romana, et al.
Publicado: (2023)

Current and potential pharmacological treatment options for insomnia in patients with alcohol use disorder in recovery
por: Roehrs, Timothy A., et al.
Publicado: (2020)

Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
por: Hu, Chenxia, et al.
Publicado: (2019)

Potential Role of Thymosin Beta 4 in Liver Fibrosis
por: Kim, Jieun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fer1repg4m12ke0uri67iumra2